ConductScience.org, home

Paper200569

Nasopharyngeal carcinoma: significance of changes in Epstein-Barr virus-related antibody patterns following therapy.

Henle W and 4 others. Int J Cancer, 1977. Cited by 146 papers, by iCite.

Cite this record

ConductScience Library. Nasopharyngeal carcinoma: significance of changes in Epstein-Barr virus-related antibody patterns following therapy. Papers, record 200569. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/200569

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Nasopharyngeal carcinoma: significance of changes in Epstein-Barr virus-related antibody patterns following therapy.
PubMed
Journal
Int J Cancer
PubMed
Year
1977
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
146
iCite
Relative citation ratio, by iCite
3.98
iCite
Revised in PubMed
2019-07-08
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Henle WW
2Ho JHJ H
3Henle GG
4Chau JCJ C
5Kwan HCH C

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibodies, ViralMajor topic
Carcinoma, Squamous CellMajor topic
Herpesvirus 4, HumanMajor topic
Nasopharyngeal NeoplasmsMajor topic
Follow-Up Studies
Humans
Immunoglobulin A
Immunoglobulin G
Immunoglobulin M
Neoplasm Metastasis
Neoplasm Recurrence, Local

Source PubMed

Download CSV of topics

Cited by26

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 146 citations.

PMIDTitleJournalYearIn PapersSource
37974670A Systematic Review on Clinico-Aetiopathological Trends of Nasopharyngeal Cancer in Asia.Indian J Otolaryngol Head Neck Surg2023https://conductscience.org/library/papers/37974670PubMed
35380720Plasma Epstein-Barr Virus MicroRNA BART8-3p as a Diagnostic and Prognostic Biomarker in Nasopharyngeal Carcinoma.Oncologist2022https://conductscience.org/library/papers/35380720PubMed
31709003An evaluation of HHV-6 as an etiologic agent in Hodgkin lymphoma and brain cancer using IARC criteria for oncogenicity.Infect Agent Cancer2019https://conductscience.org/library/papers/31709003PubMed
31584659Epithelial cell infection by Epstein-Barr virus.FEMS Microbiol Rev2019https://conductscience.org/library/papers/31584659PubMed
29978480A bacterial genotoxin causes virus reactivation and genomic instability in Epstein-Barr virus infected epithelial cells pointing to a role of co-infection in viral oncogenesis.Int J Cancer2019https://conductscience.org/library/papers/29978480PubMed
29673164Perspective: Contribution of Epstein-Barr virus (EBV) Reactivation to the Carcinogenicity of Nasopharyngeal Cancer Cells.Cancers (Basel)2018https://conductscience.org/library/papers/29673164PubMed
27687982Epstein-Barr virus: more than 50 years old and still providing surprises.Nat Rev Cancer2016https://conductscience.org/library/papers/27687982PubMed
26544798Screening for nasopharyngeal cancer.Cochrane Database Syst Rev2015https://conductscience.org/library/papers/26544798PubMed
25418193Epstein-Barr virus and nasopharyngeal carcinoma.Chin J Cancer2014https://conductscience.org/library/papers/25418193PubMed
25261366Epstein-Barr virus BALF3 mediates genomic instability and progressive malignancy in nasopharyngeal carcinoma.Oncotarget2014https://conductscience.org/library/papers/25261366PubMed
24376853Reactive oxygen species mediate Epstein-Barr virus reactivation by N-methyl-N'-nitro-N-nitrosoguanidine.PLoS One2013https://conductscience.org/library/papers/24376853PubMed
23409137Epstein-Barr virus Zta upregulates matrix metalloproteinases 3 and 9 that synergistically promote cell invasion in vitro.PLoS One2013https://conductscience.org/library/papers/23409137PubMed
23024765The synergistic effect of chemical carcinogens enhances Epstein-Barr virus reactivation and tumor progression of nasopharyngeal carcinoma cells.PLoS One2012https://conductscience.org/library/papers/23024765PubMed
18234802Epstein-Barr virus lytic transactivator Zta enhances chemotactic activity through induction of interleukin-8 in nasopharyngeal carcinoma cells.J Virol2008https://conductscience.org/library/papers/18234802PubMed
15450122Cytokine and immunoglobulin production by PWM-stimulated peripheral and tumor-infiltrating lymphocytes of undifferentiated nasopharyngeal carcinoma (NPC) patients.BMC Cancer2004https://conductscience.org/library/papers/15450122PubMed
15182432Diagnostic value of serum EBV-DNA quantification and antibody to viral capsid antigen in nasopharyngeal carcinoma patients.Cancer Sci2004https://conductscience.org/library/papers/15182432PubMed
9137098The mechanism of Epstein-Barr virus infection in nasopharyngeal carcinoma cells.Am J Pathol1997https://conductscience.org/library/papers/9137098PubMed
8126200Prevalence of Taiwan variant of Epstein-Barr virus in throat washings from patients with head and neck tumors in Taiwan.J Clin Microbiol1994https://conductscience.org/library/papers/8126200PubMed
6323549An immunoperoxidase assay for the detection of specific IgA antibody in Epstein-Barr virus infections.J Clin Pathol1984https://conductscience.org/library/papers/6323549PubMed
6318710The capsid antigen of Epstein-Barr virus in nasopharyngeal carcinomas: comparison of serum antibody titre, cellular antigen content and histopathology.Arch Otorhinolaryngol1984https://conductscience.org/library/papers/6318710PubMed

See all 26 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/200569

GET https://conductscience.org/api/papers/v1/200569/cited_by?page=2